Telemus Capital, LLC Igm Biosciences, Inc. Transaction History

Telemus Capital, LLC

  • $1.2 Billion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$47.41 - $115.03 $474,099 - $1.15 Million
-10,000 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$43.0 - $84.01 $215,000 - $420,050
5,000 Added 100.0%
10,000 $751,000
Q2 2020

Jul 17, 2020
BUY
$51.3 - $75.21 $51,300 - $75,210
1,000 Added 25.0%
5,000 $354,000
Q1 2020

Jun 05, 2020
BUY
$31.51 - $73.75 $126,040 - $295,000
4,000 New
4,000 $259,000

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $274M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email